Trial Profile
A Study to Evaluate the Efficacy of Valganciclovir or Ganciclovir for Treatment of Cytomegalovirus Infections in Liver Transplant Recipients after 3 Months Valganciclovir Prophylaxis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary) ; Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 20 Jun 2016 New trial record